Although MAF is known for its oncogenic translocation in multiple myeloma20, when the gene expression levels between cancer tissues and their normal counterparts were compared using GEPIA, MAF downregulation, rather than its upregulation was frequently observed. This evidence concerns the gene MAF and cancer.